← Leaderboards
Charles K Grieshaber
Xanthus Life Sciences, Inc.
$1,474,135
Attributed
$1,474,135
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,474,135 · 1
By mechanism
R44$1,474,135 · 1
Top collaborators
No co-investigators on record.
Most similar at Xanthus Life Sciences, Inc.
Same institution · by research overlap
- John Lister-James$1,119,568
Others in their field
Top investigators on “Acetylation”
- David A Bennett · Rush University Medical Center$25,513,948
- Shelley L Berger · University Of Pennsylvania$22,878,192
- Ming-Ming Zhou · Mount Sinai School Of Medicine Of Nyu$21,618,940
- Bing Ren · Ludwig Institute For Cancer Research$20,720,312
- Eric M Verdin · J. David Gladstone Institutes$19,319,184
- Melanie Maria Ott · J. David Gladstone Institutes$18,930,356
Research focus
AcetylationBreast NeoplasmsClinical ResearchClinical TrialsDosageFemaleHuman SubjectMethod DevelopmentNeoplasm /Cancer EpidemiologyNeoplasm /Cancer PharmacologyNeoplasm /Cancer TherapyPatient Oriented ResearchPharmacokineticsWomen'S Health